8 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings, in CNY as reported — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | CN¥807M | CN¥95M | 67.9% | 8.3% | 9.6% | 7.0% | CN¥46M | — | CN¥1.2B |
| 2024 | CN¥922M | CN¥99M | 69.4% | 7.8% | 10.3% | 6.9% | CN¥51M | — | CN¥1.1B |
| 2023 | CN¥1.0B | CN¥181M | 70.8% | 15.7% | 18.9% | 12.5% | CN¥166M | — | CN¥1.2B |
| 2022 | CN¥986M | CN¥110M | 70.1% | 11.3% | 14.3% | 8.2% | CN¥182M | — | CN¥1.0B |
| 2021 | CN¥945M | -CN¥37M | 69.9% | -5.7% | -6.1% | -3.4% | CN¥6M | — | CN¥855M |
| 2020 | CN¥532M | -CN¥37M | 68.7% | -8.4% | -5.8% | -3.6% | CN¥207M | — | CN¥862M |
| 2019 | CN¥219M | -CN¥276M | 61.5% | -127.5% | 203.7% | -163.7% | CN¥40M | — | CN¥105M |
| 2018 | CN¥132M | -CN¥18M | 50.1% | -16.7% | 27.6% | — | -CN¥5M | — | — |
Over the past 5 years, iHuman Inc.'s revenue has grown 8.7% per year. These are computed facts, not advice.
As of FY2025, iHuman Inc. reported — of total debt against CN¥1.2B of cash.
In FY2025, gross margin was 67.9%, operating margin 8.3%, and net margin 11.8%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — its annual and interim reports, in CNY as reported (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (annual and interim filings, reported in CNY) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.